Patient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Your Basket's Financial Footprint
Summary and investor key points for the Patient Platforms basket based on provided market capitalisation breakdown.
- Large-cap dominance implies generally lower volatility and closer tracking of broad market performance, so returns likely more stable.
- Suitable as a core portfolio holding for diversified exposure, rather than a speculative, high-growth allocation.
- Expect steady long-term appreciation rather than rapid gains; growth is likely incremental, not explosive.
ISRG: $164.04B
ILMN: $15.21B
ASML: $400.56B
- Other
About This Group of Stocks
Our Expert Thinking
We've identified companies building fundamental technological infrastructure that entire industries will depend on. These aren't simple product makers but ecosystem creators in genomics, AI, robotics, and advanced computing with deep intellectual property moats and multi-year growth runways.
What You Need to Know
This is a long-horizon investment approach. These companies are creating complex, integrated systems that may take years to fully mature but could dominate their industries once established. The rapid integration of AI is accelerating development timelines and expanding potential applications.
Why These Stocks
Each company selected is an undisputed technology leader with significant intellectual property and a platform others build upon. They represent the essential building blocks of future technological revolutions, with innovations that will likely power the next wave of scientific and industrial advancement.
Why You'll Want to Watch These Stocks
The Future Belongs to Platform Builders
These companies aren't just creating products—they're building the essential infrastructure that entire industries will depend on for decades. They're laying the groundwork for technologies we can barely imagine today.
AI is Accelerating Everything
The rapid integration of artificial intelligence is dramatically speeding up development cycles for these platform technologies. What might have taken a decade is now happening in years, creating potential growth catalysts.
Intellectual Property Powerhouses
These companies have built deep moats of intellectual property and technical expertise that can't be easily replicated. Their fundamental technologies are protected by patents and know-how that keeps competitors at bay.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Antiviral M&A Wave: Biotech Opportunities in 2025
Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.
Streaming Power Dynamics Explained | Content Wars
The resolution of the content dispute between Disney and Google's YouTube TV highlights the critical interdependence of content creators and distributors. This dynamic creates an investment opportunity in companies that are central to the streaming ecosystem, from content production to platform delivery.
Jeep Hybrid Recall Overview: Market Shift Analysis
Stellantis is recalling nearly 113,000 Jeep plug-in hybrids because of a serious engine defect, creating potential investment opportunities. This theme focuses on competing automakers and aftermarket parts suppliers that may benefit from a shift in consumer confidence and repair needs.